|Articles|May 9, 2020
COVID-19: How Orbis International is managing operations
Author(s)Alex Delaney-Gesing
Advertisement
Danny Haddad, MD, chief of program at
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
New tried-and-true treatments for retinal vein occlusion
2
FDA expands faricimab label to include treatment of macular edema secondary to retinal vein occlusion beyond 6 months
3
Ocugen completes dosing early in phase 2/3 GARDian3 trial for Stargardt disease
4






















